CardioSource WorldNews | Page 21
SUDDEN
CARDIAC
D E AT H
post-PCI and post-MI
15
in
post-PCI
patients are at
(1)
Ejection Fraction
is the most powerful predictor
of long-term mortality.(1)
The majority of mortality
in post-PCI patients
with low EF occurs in the
3
first
months.
(1)
Assess It.
Discuss It.
Prevent It.
high risk of dying.
2.5
2.0
1.5
LVEF
1.0
The risk of SCD post-MI is highest
during the first 30 days.(2,3)
EF > 40% (n=2406)
0.5
Rate of Sudden Death or
Cardiac Arrest with Resuscitation
(%/mo)
1 2 3 4 5 6
12
24
36
48
Post-MI patients with HF are at
4-6 times
greater risk of SCD in the
85%
first 30 days
after MI.(2,3)
MI
Find tools to help
assess your
patients’ risk @
≤ 30% (n=3852)
LVEF 31-40% (n=4998)
of 1 year mortality occurs in the
first 3 months post-PCI.(1)
HF+MI
High-risk post-PCI
patients
SCDFacts.org
experience
significant
mortality during
recovery from
revascularization.
BOTTOM LINE
1in10
high-risk post-PCI
patients die, with about
The CADILLAC Trial
3
month
mortality
post-PCI (1)
11%
Cleveland Clinic Registry
13%
12%
60%
EF ≤35% - post-PCI (4)
Without
STEMI
With
32%
STEMI
CATH PCI - NCDR Registry
EF <30%
post-PCI >65yo (5)
With
STEMI
of this mortality
due to
SUDDEN CARDIAC DEATH.
(1,6)
SOURCES: 1. Halkin A et al. Prediction of Mortality After Primary Percutaneous Coronary Intervention for Acute Myocardial
Infarction: CADILLAC Risk Score. JACC 2005;45:1397–1405. 2. Adabag AS et al. Sudden Death After Myocardial Infarction. JAMA
2008;300:2022–2029. 3. Solomon SD et al. Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction,
Heart Failure, or Both. NEJM 2005;352:2581–2588. 4. Zishiri ET et al. Early Risk of Mortality after Coronary Artery Revascularization
in Patients with Left Ventricular Dysfunction and Potential Role of the Wearable Cardioverter Defibrillator. Circulation: Arrhythmia
and Electrophysiology. 2013;6:117–128. 5. Weintraub WS et al. Prediction of Long-Term Mortality After Percutaneous Coronary
Intervention in Older Adults: Results From the National Cardiovascular Data Registry. Circulation: 2012;125:1501–1510. 6. Stone G
et al. Prevention of Sudden Cardiac Arrest Post PTCA in High-Risk Patients. http://www.theheart.org/article/1202823.do (April 2011).
Blue™ Gel - Only LifeVest has Blue™ gel.
© 2015 ZOLL Medical Corporation. ZOLL, LifeVest, Blue, and the color Blue are trademarks
and/or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries.
20C0385 Rev A